Literature DB >> 10397620

NO donor and biological properties of different benzofuroxans.

C Medana1, A Di Stilo, S Visentin, R Fruttero, A Gasco, D Ghigo, A Bosia.   

Abstract

PURPOSE: To investigate the effect of benzofusion on NO donor properties and related biological activities of the furoxan system. The biological properties considered were the ability to increase the cytosolic levels of cGMP in C6 cells and vasodilation.
METHODS: NO donor properties were investigated either in the presence or the absence of cysteine by using the Griess reaction, chemiluminescence, and gas chromatography. Increase of cytosolic cGMP levels were evaluated by radioimmunoassay. Vasodilating activity was assessed on rat aorta strips precontracted with noradrenaline, in the presence and the absence of oxyhemoglobin (HbO2) and methylene blue (MB), respectively.
RESULTS: Benzofuroxan and its methyl and cyano derivatives were unable to release NO under the experimental conditions. Generally these compounds displayed feeble vasodilating properties and were able to weakly stimulate soluble guanylate cyclase (sGC). By contrast, benzodifuroxan and benzotrifuroxan were able to produce both NO* and its reduced form NO- , the nitroxyl anion. They displayed potent vasodilating properties and were able to increase cytosolic levels of cGMP in a concentration-dependent manner.
CONCLUSIONS: The simple benzofuroxans considered here are devoid of the capability to release NO, they weakly stimulate sGC as well as manifest feeble vasodilating properties by a mechanism that does not involve a thiol-induced NO production. By contrast, benzodifuroxan and benzotrifuroxan behave as typical NO donor furoxans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397620     DOI: 10.1023/a:1018974409622

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Evidence for nitroxyl in the catalase-mediated bioactivation of the alcohol deterrent agent cyanamide.

Authors:  H T Nagasawa; E G DeMaster; B Redfern; F N Shirota; D J Goon
Journal:  J Med Chem       Date:  1990-12       Impact factor: 7.446

2.  Water soluble furoxan derivatives as NO prodrugs.

Authors:  G Sorba; C Medana; R Fruttero; C Cena; A Di Stilo; U Galli; A Gasco
Journal:  J Med Chem       Date:  1997-02-14       Impact factor: 7.446

Review 3.  No-donors: an emerging class of compounds in medicinal chemistry.

Authors:  A Gasco; R Fruttero; G Sorba
Journal:  Farmaco       Date:  1996-10

Review 4.  Benzofurazans and benzofuroxans: biochemical and pharmacological properties.

Authors:  P Ghosh; B Ternai; M Whitehouse
Journal:  Med Res Rev       Date:  1981       Impact factor: 12.944

5.  Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry.

Authors:  P S Wong; J Hyun; J M Fukuto; F N Shirota; E G DeMaster; D W Shoeman; H T Nagasawa
Journal:  Biochemistry       Date:  1998-04-21       Impact factor: 3.162

6.  Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans.

Authors:  M Feelisch; K Schönafinger; E Noack
Journal:  Biochem Pharmacol       Date:  1992-09-25       Impact factor: 5.858

7.  Potential antileukemic and immunosuppressive drugs. 3. Effects of homocyclic ring substitution on the in vitro drug activity of 4-nitrobenzo-2,1,3-oxadiazoles (4-nitrobenzofurazans) and their N-oxides (4-nitrobenzofuroxans).

Authors:  P B Ghosh; B Ternai; M W Whitehouse
Journal:  J Med Chem       Date:  1972-03       Impact factor: 7.446

8.  The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor.

Authors:  J M Fukuto; K Chiang; R Hszieh; P Wong; G Chaudhuri
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

Review 9.  Measurement of nitric oxide in biological models.

Authors:  S Archer
Journal:  FASEB J       Date:  1993-02-01       Impact factor: 5.191

10.  A new class of furoxan derivatives as NO donors: mechanism of action and biological activity.

Authors:  R Ferioli; G C Folco; C Ferretti; A M Gasco; C Medana; R Fruttero; M Civelli; A Gasco
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

  10 in total
  6 in total

1.  Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.

Authors:  Isaac T Schiefer; Lawren VandeVrede; Mauro Fa'; Ottavio Arancio; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2012-03-30       Impact factor: 7.446

2.  Searching for balanced hybrid NO-donor 1,4-dihydropyridines with basic properties.

Authors:  D Boschi; G Caron; S Visentin; A Di Stilo; B Rolando; R Fruttero; A Gasco
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

3.  The study of NADPH-dependent flavoenzyme-catalyzed reduction of benzo[1,2-c]1,2,5-oxadiazole N-oxides (benzofuroxans).

Authors:  Jonas Šarlauskas; Lina Misevičienė; Audronė Marozienė; Laimonas Karvelis; Jonita Stankevičiūtė; Kastis Krikštopaitis; Narimantas Čėnas; Aleksey Yantsevich; Audrius Laurynėnas; Žilvinas Anusevičius
Journal:  Int J Mol Sci       Date:  2014-12-15       Impact factor: 5.923

Review 4.  NO donors and NO delivery methods for controlling biofilms in chronic lung infections.

Authors:  Yu-Ming Cai; Ying-Dan Zhang; Liang Yang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-03       Impact factor: 5.560

5.  Highly conjugated architectures and labile reaction intermediates from coupling between 10π electron-deficient heteroaromatics and sym-trihydroxy- or triamino-benzene derivatives.

Authors:  Gabriele Micheletti; Carla Boga; Silvia Cino; Silvia Bordoni; Elena Chugunova
Journal:  RSC Adv       Date:  2018-12-13       Impact factor: 4.036

6.  4,6-Dichloro-5-Nitrobenzofuroxan: Different Polymorphisms and DFT Investigation of Its Reactivity with Nucleophiles.

Authors:  Elena Chugunova; Nurgali Akylbekov; Alexey Dobrynin; Alexander Burilov; Carla Boga; Gabriele Micheletti; Vincenzo Frenna; Edoardo Jun Mattioli; Matteo Calvaresi; Domenico Spinelli
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.